These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15476907)

  • 1. In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis.
    De Clerck F; Somers Y; Mannaert E; Greenspan A; Eerdekens M
    Clin Ther; 2004 Aug; 26(8):1261-73. PubMed ID: 15476907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.
    Dremencov E; El Mansari M; Blier P
    Psychopharmacology (Berl); 2007 Sep; 194(1):63-72. PubMed ID: 17530476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):263-79. PubMed ID: 1180617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists.
    Knight JA; Smith C; Toohey N; Klein MT; Teitler M
    Mol Pharmacol; 2009 Feb; 75(2):374-80. PubMed ID: 18996971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists.
    Khan N; Farooq AD; Sadek B
    Drug Des Devel Ther; 2015; 9():3497-506. PubMed ID: 26185418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation.
    Dietrich-Muszalska A; Rabe-Jablonska J; Nowak P; Kontek B
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):268-75. PubMed ID: 20218792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.
    Kwon HW; Shin JH; Lim DH; Ok WJ; Nam GS; Kim MJ; Kwon HK; Noh JH; Lee JY; Kim HH; Kim JL; Park HJ
    BMC Complement Altern Med; 2016 Dec; 16(1):508. PubMed ID: 27927214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
    de Clerck F; David JL; Janssen PA
    Agents Actions; 1982 Jul; 12(3):388-97. PubMed ID: 6215842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists".
    Toohey N; Klein MT; Knight J; Smith C; Teitler M
    Mol Pharmacol; 2009 Sep; 76(3):552-9. PubMed ID: 19509219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
    Malyszko J; Urano T; Knofler R; Taminato A; Yoshimi T; Takada Y; Takada A
    Thromb Res; 1994 Sep; 75(5):569-76. PubMed ID: 7992257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats.
    Kozielska M; Johnson M; Pilla Reddy V; Vermeulen A; Li C; Grimwood S; de Greef R; Groothuis GM; Danhof M; Proost JH
    Pharm Res; 2012 Jul; 29(7):1932-48. PubMed ID: 22437487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of ketanserin on hemostasis in vitro.
    Bergqvist D; Arvidsson S; Haglund U; Hedner U; Lindblad B
    Thromb Res; 1986 Jul; 43(2):237-41. PubMed ID: 2943051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human platelet function by verapamil.
    Addonizio VP; Fisher CA; Strauss JF; Edmunds LH
    Thromb Res; 1982 Nov; 28(4):545-56. PubMed ID: 7164035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets.
    Ogawa T; Sugidachi A; Asai F; Koike H
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):233-40. PubMed ID: 9663705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.